Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2016

30.04.2016 | Clinical Study

Parameters influencing local control of meningiomas treated with radiosurgery

verfasst von: Tania Kaprealian, David R. Raleigh, Penny K. Sneed, Nima Nabavizadeh, Jean L. Nakamura, Michael W. McDermott

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

To identify parameters that influence local control after stereotactic radiosurgery (SRS) for meningiomas we retrospectively analyzed all meningiomas treated with Gamma Knife SRS at our institution from 1991 to 2007. Endpoints were measured from the date of SRS and estimated using the Kaplan–Meier method; subgroups were compared with log-rank tests. Sex, performance status, age, SRS setting, radiation dose, grade, volume and location were evaluated with univariate and multivariate Cox proportional hazards analyses. Of 280 patients with 438 tumors, 264 patients with clinical follow-up and 406 tumors with imaging follow-up were analyzed (median follow-up: 75.9 months). Thirty-seven percent of the tumors had no tissue diagnosis, 32 % were benign (grade I), 12 % atypical (grade II), and 19 % malignant (grade III). Five-year freedom from progression (FFP) was 97 % for presumed meningiomas, 87 % for grade I tumors, 56 % for grade II tumors, and 47 % for grade III tumors (p < 0.0001). Five-year FFP probabilities for upfront SRS versus SRS at recurrence after surgery versus SRS at recurrence after RT were 97, 86, and 38 %, respectively (p < 0.0001). Univariate analysis revealed that higher grade, larger target volume (median diameter: 2.4 cm) and SRS setting were associated with poorer FFP. Only target volume and SRS setting remained significant on multivariate analysis. Local control of presumed and grade I meningiomas is excellent with Gamma Knife SRS, but is suboptimal with high-grade tumors as well as for those treated at recurrence after RT or of large volume.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro-oncology 16(Suppl 4):iv1–iv63CrossRefPubMedPubMedCentral Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro-oncology 16(Suppl 4):iv1–iv63CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, Schiff D, Weber DC, Wen PY, Vogelbaum MA (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122:4–23CrossRefPubMed Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, Schiff D, Weber DC, Wen PY, Vogelbaum MA (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122:4–23CrossRefPubMed
3.
Zurück zum Zitat Santacroce A, Walier M, Régis J et al (2012) Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery 70:32–39 (discussion 39) CrossRefPubMed Santacroce A, Walier M, Régis J et al (2012) Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery 70:32–39 (discussion 39) CrossRefPubMed
4.
Zurück zum Zitat Stafford SL, Pollock BE, Foote RL, Link MJ, Gorman DA, Schomberg PJ, Leavitt JA (2001) Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 49:1029–1037 (discussion 1037–8) PubMed Stafford SL, Pollock BE, Foote RL, Link MJ, Gorman DA, Schomberg PJ, Leavitt JA (2001) Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 49:1029–1037 (discussion 1037–8) PubMed
5.
Zurück zum Zitat Przybylowski CJ, Raper DMS, Starke RM, Xu Z, Liu KC, Sheehan JP (2015) Stereotactic radiosurgery of meningiomas following resection: predictors of progression. J Clin Neurosci 22:161–165CrossRefPubMed Przybylowski CJ, Raper DMS, Starke RM, Xu Z, Liu KC, Sheehan JP (2015) Stereotactic radiosurgery of meningiomas following resection: predictors of progression. J Clin Neurosci 22:161–165CrossRefPubMed
6.
Zurück zum Zitat Sheehan JP, Starke RM, Kano H et al (2014) Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study. J Neurosurg 120:1268–1277CrossRefPubMed Sheehan JP, Starke RM, Kano H et al (2014) Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study. J Neurosurg 120:1268–1277CrossRefPubMed
7.
Zurück zum Zitat Starke R, Kano H, Ding D et al (2014) Stereotactic radiosurgery of petroclival meningiomas: a multicenter study. J Neurooncol 119:169–176CrossRefPubMed Starke R, Kano H, Ding D et al (2014) Stereotactic radiosurgery of petroclival meningiomas: a multicenter study. J Neurooncol 119:169–176CrossRefPubMed
8.
Zurück zum Zitat Starke RM, Przybylowski CJ, Sugoto M, Fezeu F, Awad AJ, Ding D, Nguyen JH, Sheehan JP (2015) Gamma Knife radiosurgery of large skull base meningiomas. J Neurosurg 122:363–372CrossRefPubMed Starke RM, Przybylowski CJ, Sugoto M, Fezeu F, Awad AJ, Ding D, Nguyen JH, Sheehan JP (2015) Gamma Knife radiosurgery of large skull base meningiomas. J Neurosurg 122:363–372CrossRefPubMed
9.
Zurück zum Zitat Ding D, Starke RM, Kano H et al (2014) Gamma knife radiosurgery for cerebellopontine angle meningiomas: a multicenter study. Neurosurgery 75:398–408 (quiz 408) CrossRefPubMed Ding D, Starke RM, Kano H et al (2014) Gamma knife radiosurgery for cerebellopontine angle meningiomas: a multicenter study. Neurosurgery 75:398–408 (quiz 408) CrossRefPubMed
10.
Zurück zum Zitat Park S-H, Kano H, Niranjan A, Flickinger JC, Lunsford LD (2014) Stereotactic radiosurgery for cerebellopontine angle meningiomas. J Neurosurg 120:708–715CrossRefPubMed Park S-H, Kano H, Niranjan A, Flickinger JC, Lunsford LD (2014) Stereotactic radiosurgery for cerebellopontine angle meningiomas. J Neurosurg 120:708–715CrossRefPubMed
11.
Zurück zum Zitat Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455–1465CrossRefPubMed Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455–1465CrossRefPubMed
12.
Zurück zum Zitat Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046–2056PubMed Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046–2056PubMed
13.
Zurück zum Zitat Clark VE, Erson-Omay EZ, Serin A et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077–1080CrossRefPubMedPubMedCentral Clark VE, Erson-Omay EZ, Serin A et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077–1080CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Pollock BE, Stafford SL, Link MJ, Brown PD, Garces YI, Foote RL (2012) Single-fraction radiosurgery of benign intracranial meningiomas. Neurosurgery 71:604–612 (discussion 613) CrossRefPubMed Pollock BE, Stafford SL, Link MJ, Brown PD, Garces YI, Foote RL (2012) Single-fraction radiosurgery of benign intracranial meningiomas. Neurosurgery 71:604–612 (discussion 613) CrossRefPubMed
16.
Zurück zum Zitat Sethi RA, Rush SC, Liu S, Sethi SA, Parker E, Donahue B, Narayana A, Silverman J, Kondziolka D, Golfinos JG (2015) Dose-response relationships for meningioma radiosurgery. Am J Clin Oncol 38:600–604CrossRefPubMed Sethi RA, Rush SC, Liu S, Sethi SA, Parker E, Donahue B, Narayana A, Silverman J, Kondziolka D, Golfinos JG (2015) Dose-response relationships for meningioma radiosurgery. Am J Clin Oncol 38:600–604CrossRefPubMed
17.
Zurück zum Zitat Kaur G, Sayegh ET, Larson A, Bloch O, Madden M, Sun MZ, Barani IJ, James CD, Parsa AT (2014) Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro-oncology 16:628–636CrossRefPubMedPubMedCentral Kaur G, Sayegh ET, Larson A, Bloch O, Madden M, Sun MZ, Barani IJ, James CD, Parsa AT (2014) Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro-oncology 16:628–636CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB, Rhoton AL (1997) Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39:427–436CrossRefPubMed Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB, Rhoton AL (1997) Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39:427–436CrossRefPubMed
19.
Zurück zum Zitat Kondziolka D, Levy EI, Niranjan A, Flickinger JC, Lunsford LD (1999) Long-term outcomes after meningioma radiosurgery: physician and patient perspectives. J Neurosurg 91:44–50CrossRefPubMed Kondziolka D, Levy EI, Niranjan A, Flickinger JC, Lunsford LD (1999) Long-term outcomes after meningioma radiosurgery: physician and patient perspectives. J Neurosurg 91:44–50CrossRefPubMed
20.
Zurück zum Zitat Iglesias Gómez JC, Mosquera Orgueira A (2014) An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation. Front Oncol 4:147PubMedPubMedCentral Iglesias Gómez JC, Mosquera Orgueira A (2014) An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation. Front Oncol 4:147PubMedPubMedCentral
21.
Zurück zum Zitat Goutagny S, Nault JC, Mallet M, Henin D, Rossi JZ, Kalamarides M (2014) High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol 24:184–189CrossRefPubMed Goutagny S, Nault JC, Mallet M, Henin D, Rossi JZ, Kalamarides M (2014) High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol 24:184–189CrossRefPubMed
22.
Zurück zum Zitat Zhang X, Jia H, Lu Y, Dong C, Hou J, Wang Z, Wang F, Zhong H, Wang L, Wang K (2014) Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes. Discov Med 18:301–311PubMedPubMedCentral Zhang X, Jia H, Lu Y, Dong C, Hou J, Wang Z, Wang F, Zhong H, Wang L, Wang K (2014) Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes. Discov Med 18:301–311PubMedPubMedCentral
23.
Zurück zum Zitat Beauchamp RL, James MF, DeSouza PA et al (2015) A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. Oncotarget 6:16981–16997CrossRefPubMedPubMedCentral Beauchamp RL, James MF, DeSouza PA et al (2015) A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. Oncotarget 6:16981–16997CrossRefPubMedPubMedCentral
Metadaten
Titel
Parameters influencing local control of meningiomas treated with radiosurgery
verfasst von
Tania Kaprealian
David R. Raleigh
Penny K. Sneed
Nima Nabavizadeh
Jean L. Nakamura
Michael W. McDermott
Publikationsdatum
30.04.2016
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2016
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-016-2121-1

Weitere Artikel der Ausgabe 2/2016

Journal of Neuro-Oncology 2/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.